tsg 101 Inhibitors

TSG101 inhibitors represent a class of compounds designed to impede the function of the Tumor Susceptibility Gene 101 (TSG101) protein. TSG101 plays a pivotal role in cellular processes, particularly in the endosomal sorting complex required for transport (ESCRT) pathway. This pathway is crucial for sorting and trafficking various proteins within cells, particularly during the formation of multivesicular bodies (MVBs) and the subsequent process of protein degradation through the lysosomal pathway. TSG101, as a component of the ESCRT-I complex, aids in the recognition of ubiquitinated cargo proteins, facilitating their sorting into MVBs and subsequent degradation. Inhibitors targeting TSG101 interfere with this fundamental process by obstructing its interactions within the ESCRT machinery, thus disrupting the proper sorting and trafficking of proteins destined for degradation.

This disruption ultimately leads to alterations in the cellular protein degradation machinery, influencing various cellular processes and pathways that rely on the efficient turnover of proteins. Chemical entities classified as TSG101 inhibitors often act by binding to specific regions on the TSG101 protein or by disrupting protein-protein interactions crucial for the assembly and functioning of the ESCRT complex.